Nowa Zelandia - angielski - Medsafe (Medicines Safety Authority)

merck sharp & dohme (new zealand) limited - diclofenamide 50mg - tablet - 50 mg - active: diclofenamide 50mg

Wielka Brytania - angielski - MHRA (Medicines & Healthcare Products Regulatory Agency)

imported (italy) - diclofenamide - oral tablet - 50mg

Wielka Brytania - angielski - MHRA (Medicines & Healthcare Products Regulatory Agency)

imported (united states) - diclofenamide - oral tablet - 50mg

Irlandia - angielski - HPRA (Health Products Regulatory Authority)

merck sharp and dohme limited - diclofenamide - tablets - 50 milligram

Stany Zjednoczone - angielski - NLM (National Library of Medicine)

aphena pharma solutions - tennessee, inc. - diclofenac sodium (unii: qtg126297q) (diclofenac - unii:144o8ql0l1) - diclofenac sodium 50 mg - carefully consider the potential benefits and risks of diclofenac and other treatment options before deciding to use diclofenac sodium delayed-release tablets. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings ). diclofenac is indicated: - for relief of signs and symptoms of osteoarthritis - for relief of signs and symptoms of rheumatoid arthritis - for acute or long-term use in the relief of signs and symptoms of ankylosing spondylitis diclofenac sodium delayed-release tablets are contraindicated in patients with known hypersensitivity to diclofenac. diclofenac should not be given to patients who have experienced asthma, urticaria, or other allergic-type reactions after taking aspirin or other nsaids. severe, rarely fatal, anaphylactic-like reactions to nsaids have been reported in such patients (see warnings, anaphylactoid reactions , and precautions, preexisting asthma ). diclofenac are contraindicated for the treatment of peri-operati

Australia - angielski - Department of Health (Therapeutic Goods Administration)

blackmores ltd - symphytum officinale -

Kanada - angielski - Health Canada

pharma stulln inc. - diclofenac sodium - solution - 0.1% - diclofenac sodium 0.1% - antiallergic agents

Australia - angielski - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - metformin hydrochloride, quantity: 500 mg - tablet, modified release - excipient ingredients: povidone; colloidal anhydrous silica; hypromellose; magnesium stearate - treatment of type 2 diabetes mellitus in adults, particularly in overweight patients, when dietary management and exercise alone does not result in adequate glycaemic control. metformin modified release tablets may be used as monotherapy or in combination with other oral antidiabetic agents, or with insulin.

Australia - angielski - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - metformin hydrochloride, quantity: 1000 mg - tablet, modified release - excipient ingredients: povidone; colloidal anhydrous silica; hypromellose; magnesium stearate - treatment of type 2 diabetes mellitus in adults, particularly in overweight patients, when dietary management and exercise alone does not result in adequate glycaemic control. metformin modified release tablets may be used as monotherapy or in combination with other oral antidiabetic agents, or with insulin.

Australia - angielski - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - metformin hydrochloride -